Journals / Turkish Journal of Medical Sciences / 2021 / Cilt: 51 - Sayı: 4

Effects of intracerebroventricularly administered opioid peptide antagonists on tissue glycogen levels in rats after exercise

Pages
2185–2192
Publication Date
2022-11-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Our findings indicate that icv administered opioid peptide antagonists may play a role in glycogen metabolism in peripheral tissues such as skeletal muscle, heart, and liver.Keywords: Exercise, glycogen, endogenous opioid peptide, naloxone, naltrindole

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: Physical exercise is a state of physiological stress that requires adaptation of the organism to physical activity.
📊
Key Findings & Data:Materials and methods: Rats had intracerebroventricularly (icv) received nonspecific opioid peptide receptor antagonist, naloxone (50 μg/10 μL in saline) and δ-opioid receptor-selective antagonist naltrindole (50 μg/10 μL in saline) and then exercised till exhaustion.
💡
Conclusion & Impact:Conclusion: Our findings indicate that icv administered opioid peptide antagonists may play a role in glycogen metabolism in peripheral tissues such as skeletal muscle, heart, and liver.Keywords: Exercise, glycogen, endogenous opioid peptide, naloxone, naltrindole
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background/aim: Physical exercise is a state of physiological stress that requires adaptation of the organism to physical activity. Glycogen is an important and essential energy source for muscle contraction. Skeletal muscle and liver are two important glycogen stores, and the energy required to maintain exercise in rodents are provided by destruction of this glycogen depot. In this study, the effects of endogenous opioid peptide antagonism at the central nervous system level on tissue glycogen content after exhaustive exercise were investigated. Materials and methods: Rats had intracerebroventricularly (icv) received nonspecific opioid peptide receptor antagonist, naloxone (50 μg/10 μL in saline) and δ-opioid receptor-selective antagonist naltrindole (50 μg/10 μL in saline) and then exercised till exhaustion. After exhaustion, skeletal muscle, heart, and liver were excised immediately. Results: Both opioid peptide antagonists decreased glycogen levels in skeletal muscle. Although, in soleus muscle, this decrease was not statistically significant (p > 0.05), in gastrocnemius muscle, it was significant in the icv naloxone administered group compared with control (p < 0.05). Heart glycogen levels increased significantly in both naloxone and naltrindole groups compared to control and sham-operated groups (p < 0.05). Heart glycogen levels were higher in the naloxone group than naltrindole (p < 0.05). Liver glycogen levels were elevated significantly with icv naloxone administration compared with the control group (p < 0.05). Glycogen levels in the naloxone group was also significantly higher than the naltrindole group (p < 0.05). Conclusion: Our findings indicate that icv administered opioid peptide antagonists may play a role in glycogen metabolism in peripheral tissues such as skeletal muscle, heart, and liver.Keywords: Exercise, glycogen, endogenous opioid peptide, naloxone, naltrindole

🔖

Cite This Article

GÜNEY, Ş., DİNCER, S., İLHAN, A. Ş. (2022). Effects of intracerebroventricularly administered opioid peptide antagonists on tissue glycogen levels in rats after exercise. Turkish Journal of Medical Sciences, Cilt: 51 - Sayı: 4, 2185–2192. https://ajindex.com/articles/609787

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (3)

  1. Fox EL, Bowers RW, Foss ML. Energy Sources In: The physiological basis of physical education and athletics. 4th ed. Dubuque (Iowa): wcb Publishers, 1989
  2. Roach PJ, Skurat AV, Haris RA. Regulation of glycogen metabolism. In: Cherrington AD, Jefferson LS (editors). The endocrine pancreas and regulation of metabolism, (NY), Oxford University Press; 2001
  3. Vøllestad NK, Blom PCS. Effect of varying exercise intensity on glycogen depletion in human muscle fibers. Acta Physiologica Scandinavica 1985; 125 (3): 395-405. doi: 10.1111/j.1748- 1716.1985.tb07735.x 4. Hargreaves M, McConell G, Proietto J. Influence of muscle glycogen on glycogenolysis and glucose uptake during exercise. Journal of Applied Physiology 1985; 78: 288-292. doi: 10.1152/ jappl.1995.78.1.288 5. Kayser B. Exercise starts and ends in the brai. European Journal of Applied Physiology 2003; 90 (3-4): 411-419. doi: 10.1007/ s00421-003-0902-7 6. Noakes TD, Peltonen JE, Rusko HK. Evidence that a central governor regulates exercise performance during acute hypoxia and hyperoxia. The Journal of Experimental Biology 2001; 204: 3225-3234. doi: 10.1242/jeb.204.18.3225 7. Molina PE, Abumrad NN. Metabolic effects of opiates and opioid peptides. Advances in Neuroimmunology 1994; 4 (2): 105-116. doi: 10.1016/s0960-5428(05)80005-1 8. Rosa Neto JC, Lira FS, Oyama LM, Zanchi NE, Yamashita AS et al. Exhaustive exercise causes an anti-inflammatory effect in skeletal muscle and a pro-inflammatory effect in adipose tissue in rats. European Journal of Applied Physiology 2009; 106: 697-704. doi:10.1007/s00421-009-1070-1 9. Guillemin R, Vargo T, Rossier J, Minick S, Ling N et al. β-endorphin and adrenocorticotropin are selected concomitantly by the pituitary gland. Science 1977; 197 (4311): 1367-1369. doi: 10.1126/science.197601 10. Oleshansky MA, Zoltick JM, Herman RH, Mougey EH, Meyerhoff JL. The influence of fitness on neuroendocrine responses to exhaustive treadmill exercise. European Journal of Applied Physiology and Occupational Physiology 1990; 59 (6): 405-410. doi:10.1007/BF02388620 11. Sforzo GA. Opioids and exercise. An update. Sports Medicine 1989; 7 (2): 109-124. doi: 10.2165/00007256-198907020-00003 12. Harber VJ, Sutton JR. Endorphins and exercise. Sports Medicine 1984; 1: 154-171. doi: 10.2165/00007256-198401020-00004 13. Vaccarino AL, Kastin AJ. Endogenous opiates: 2000. Peptides 2001; 22: 2257-2328. doi: 10.1016/s0196-9781(01)00566-62 14. Angelopoulos TJ, Robertson RJ, Goss FL, Utter A. Insulin